Bear Stearns Health Innoventures
Overview
Bear Stearns Health Innoventures is a venture capital firm specializing in healthcare investments. The firm focuses on private equity and venture capital investments in the healthcare sector, including biopharmaceuticals, healthcare IT, healthcare services, life sciences, and medical devices & instruments. It primarily invests in early-stage, growth, and late-stage companies within the United States. The firm has a history of leading significant financing rounds, with investments ranging from $2 million to $65 million. Notable investments include Affymax, Agensys, and Raven Biotechnologies.
Investment Focus
- Innovative R&D in healthcare sector
- Lead investor preference
- Investment size between $2 million and $65 million
Portfolio Companies
Reach Bear Stearns Health Innoventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bear Stearns Health Innoventures
What sectors does Bear Stearns Health Innoventures invest in?
Bear Stearns Health Innoventures invests in Life Sciences, Healthcare Services, Biopharmaceutical, Healthcare IT and Medical Devices & Instruments, and is based in New York, United States. Bear Stearns Health Innoventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Bear Stearns Health Innoventures invest at?
Bear Stearns Health Innoventures backs companies at Early Stage, Growth and Late Stage, writing cheques of 2M - 65M.
Which regions does Bear Stearns Health Innoventures invest in?
Bear Stearns Health Innoventures invests across United States.
What companies has Bear Stearns Health Innoventures invested in?
Bear Stearns Health Innoventures's portfolio includes Agensys, Affymax, Raven Biotechnologies, TolerRx, Achillion Pharmaceuticals, Broadband National, Ash Access Technology and Entelos.
Last updated · Source: ConnectSafely investor database
